Drug intelligence / Profile preview

LIKMEZ

Development stage
Approved
Lead developer
Appili Therapeutics
Modality
Small Molecules
Administration
Oral
01

Overview

ATI-1501 (LIKMEZ) is a taste-masked, liquid oral suspension formulation of the antibiotic metronidazole. It was developed to provide an alternative for patients who have difficulty swallowing tablets or capsules, such as children and the elderly. The drug is indicated for the treatment of parasitic and anaerobic bacterial infections. Clinical studies have shown that a single 500 mg dose of ATI-1501 achieves equivalent systemic drug levels to a 500 mg metronidazole tablet under both fasted and fed conditions. The formulation has been optimized to improve palatability and reduce issues with non-compliance associated with the bitter taste of traditional tablet forms[2][5][6].

Brand names
LIKMEZ
Other names
metronidazole oral suspensionmetronidazole liquid oral suspensionATI-1501 liquid oral reformulation of metronidazoleATI1501 liquid oral reformulation of metronidazoleATI 1501 liquid oral reformulation of metronidazole
02

Targets

Neuraminidase

Beyond the preview

Go deeper on LIKMEZ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIKMEZ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call